Psychiatrist comes under fire from Senator Grassley for writing 96,685 psych drug prescriptions – about 153 per day

The letter from Senator Grassley does not mention Fernando Mendez-Villamil by name, but it cites documents from the Florida Agency for Healthcare Administration about a prescriber who wrote 96,685 prescriptions for from the last quarter of 2007 through the first quarter of 2009 for Medicaid patients. Mendez-Villamil wrote nearly twice as many prescriptions for psychiatric drugs as the No. 2 Medicaid prescriber in the state.

That British Drug Maker Glaxo’s $1 Billion Paxil Settlements Were Disclosed by Press – Not Drug Maker – Is Cause for Concern

The fact that GlaxoSmithKline (GSK) has paid $1 billion to settle lawsuits related to Paxil was disclosed by Bloomberg and not the company itself illustrates how lousy financial disclosure rules are in Europe and why drug companies based there cannot be trusted to tell the truth about what is going on with their litigation liabilities and, by extension, the safety of their drugs.

NAMI – the ‘patients rights’ group which is really funded by & a major lobbying arm of Psycho/Pharma – is on the defensive

After reports that most donations made to the big advocacy group came from drug makers in recent years, the National Alliance on Mental Illness (NAMI) agreed to disclose its funding sources. The disclosure, however, came after protracted criticism of NAMI for coordinating lobbying efforts with drug makers and pushing legislation that also benefits the pharma industry.

50 to 79 Year-old Women on Antidepressants Are 45% More Likely to Have a Stroke and Are at 32% Higher Risk of Death

The study examined data from 136,293 study participants, aged 50 to 79, who were not taking antidepressants when they enrolled in the study, and who were followed for an average of six years. The researchers observed a significant difference in stroke rates: antidepressant users were 45 percent more likely to experience strokes than women who weren’t taking antidepressants. The study also found that when overall death rates (all-cause mortality) were compared between the two groups, those on antidepressants had a 32 percent higher risk of death from all causes compared with non-users.